|
MechanismPIK3R3 inhibitors |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Guangzhou Yimingkang Biotechnology Co., Ltd.
0 Patents (Medical) associated with Guangzhou Yimingkang Biotechnology Co., Ltd.
100 Deals associated with Guangzhou Yimingkang Biotechnology Co., Ltd.
100 Translational Medicine associated with Guangzhou Yimingkang Biotechnology Co., Ltd.